proxyvotesnow.com

Home › Asset managers › Dimensional › 2024-2025 › Against the board

Dimensional 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Dimensional voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

6,073 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.

Dimensional, 2024-2025 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedDimensional votedFunds
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Authorization of the Board to Handle All Related Matters Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Draft and Summary of Employee Share Purchase Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Draft and Summary of Stock Appreciation Rights Incentive Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Draft and Summary of Stock Option Incentive Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Management Method of Employee Share Purchase Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. September 13, 2024 Approve Methods to Assess the Performance of Plan Participants Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. December 6, 2024 Approve Authorization of the Board to Handle All Matters Related to Employee Share Purchase Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. December 6, 2024 Approve Employee Share Purchase Plan Compensation Board AGAINST 7
Zhongshan Broad-Ocean Motor Co., Ltd. December 6, 2024 Approve Management Method of Employee Share Purchase Plan Compensation Board AGAINST 7
Zhongtai Securities Co., Ltd. December 26, 2024 Approve Provision of Guarantee Capital Structure Board AGAINST 7
Zhuhai Huafa Properties Co., Ltd. April 7, 2025 Approve Authorization of Company Management to Carry Out External Investment Extraordinary Transactions Board AGAINST 7
Zhuhai Huafa Properties Co., Ltd. April 7, 2025 Approve Financing Guarantee and Counter Guarantee Provision and Related Party Transactions Capital Structure Board AGAINST 7
Zhuhai Huafa Properties Co., Ltd. April 7, 2025 Approve Guarantee Plan Capital Structure Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. December 25, 2024 Approve Downward Adjustment on Conversion Price of Convertible Bonds Capital Structure Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Abnormal Fluctuations in the Company's Stock Price Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Authorization of Board to Handle All Related Matters Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Company's Eligibility for Acquisition by Issuance of Shares Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transactions and Validity of the Submitted Legal Documents Regarding this Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Confidentiality Measures and Confidentiality System Adopted for this Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Confirmation of Audit Report, Pro Forma Review Report and Asset Appraisal Report Related to this Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Hiring Intermediary Agencies Related to This Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Impact of Dilution of Current Returns on Major Financial Indicators and the Relevant Measures to be Taken Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Purpose and Approach as well as the Fairness of Pricing Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Issuance Price Adjustment Mechanism Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Issue Manner and Target Subscriber Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Issue Number Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Issue Price Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Issue Type and Par Value Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Listing Location Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Lock-up Period Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Payment Methods Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Performance Commitments and Compensation Arrangements Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Report (Draft) and Summary on Company's Acquisition by Issuance of Shares and Related Party Transactions Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Resolution Validity Period Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Signing the Agreement Documents with Effective Conditions Related to this Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Target Assets Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Complies with Article 11 of Administrative Measures for the Registration of Securities Issuance by Listed Companies Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Complies with Article 11 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Complies with Article 4 of Listed Company Supervision Guidelines No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Complies with Article 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Does Not Constitute as Major Asset Restructuring and Restructuring Listing Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Does Not Exist Article 12 of Guidelines for the Supervision of Listed Companies No. 7 - Supervision of Abnormal Stock Transactions Related to Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Parties Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Plan Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transaction Price and Pricing Basis Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve Transitional Profit and Loss Arrangements Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve the Adjustment of this Transaction Plan Does Not Constitute as Major Adjustment Extraordinary Transactions Board AGAINST 7
Zhuzhou Kibing Group Co., Ltd. February 25, 2025 Approve the Purchase and Sale of Assets Within the Twelve Months Prior to this Transaction Extraordinary Transactions Board AGAINST 7
Zhuzhou Times New Materials Technology Co., Ltd. May 21, 2025 Approve Application of Credit Line Capital Structure Board AGAINST 7
Zhuzhou Times New Materials Technology Co., Ltd. May 21, 2025 Approve Provision of Guarantee Capital Structure Board AGAINST 7
accesso Technology Group Plc May 20, 2025 Approve Long Term Incentive Plan Compensation Board AGAINST 7
argenx SE May 27, 2025 Approve Remuneration Policy Compensation Board AGAINST 7
argenx SE May 27, 2025 Approve Remuneration Report Compensation Board AGAINST 7
argenx SE May 27, 2025 Reelect Anthony Rosenberg as Non-Executive Director Director Elections Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Compensation Report of Corporate Officers Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Compensation of Alexandre Merieux, Chairman of the Board Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Compensation of Pierre Boulud, CEO Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Issuance of Equity or Equity-Linked Securities up to 20 Percent of Issued Capital for Private Placements Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Remuneration Policy of CEO Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Remuneration Policy of Chairman of the Board Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Approve Remuneration Policy of Corporate Officers Compensation Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 18, 19, and 20 Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Issuance of Equity Upon Conversion of a Subsidiary's Equity-Linked Securities without Preemptive Rights for Up to EUR 4,210,280 Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights (Rights Issue) up to Aggregate Nominal Amount of EUR 4,210,280 Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 4,210,280 Capital Structure Board AGAINST 7
bioMerieux SA May 15, 2025 Reelect Fanny Letier as Director Director Elections Board AGAINST 7
bioMerieux SA May 15, 2025 Reelect Marie-Paule Kieny as Director Director Elections Board AGAINST 7
eQ Oyj March 25, 2025 Approve Remuneration Policy And Other Terms of Employment For Executive Management Compensation Board AGAINST 7
eQ Oyj March 25, 2025 Approve Remuneration Report (Advisory Vote) Compensation Board AGAINST 7
eQ Oyj March 25, 2025 Reelect Paivi Arminen, Nicolas Berner, Georg Ehrnrooth (Chair), Janne Larma and Tomas von Rettig as Directors; Elect Caroline Bertlin as New Director Director Elections Board AGAINST 7
enVVeno Medical Corporation December 18, 2024 To approve on a non-binding, advisory basis the compensation of our named executive officers. Say-on-Pay Board AGAINST 7
enVVeno Medical Corporation December 18, 2024 To elect Dr. Francis Duhay and Dr. Sanjay Shrivastava as Class I Directors, to hold office until the 2027 Annual Meeting of Stockholders or until their successor is elected and qualified or until their earlier death, incapacity, removal or resignation: Dr. Francis Duhay Director Elections Board WITHHOLD 7
7C Solarparken AG June 4, 2025 Approve Remuneration Report Compensation Board AGAINST 6
ACV Auctions Inc. May 28, 2025 Approve, on a non-binding, advisory basis, the compensation of our named executive officers; and Say-on-Pay Board AGAINST 6
ACV Auctions Inc. May 28, 2025 Elect two Class I directors: George Chamoun Director Elections Board WITHHOLD 6
ACV Auctions Inc. May 28, 2025 Elect two Class I directors: Robert P. Goodman Director Elections Board WITHHOLD 6
AECC Aviation Power Co. Ltd. December 5, 2024 Elect Mou Xin as Director Director Elections Board AGAINST 6
AEM Holdings Ltd. April 23, 2025 Approve Grant of Awards and Issuance of Shares Under AEM Performance Share Plan 2017 Compensation Board AGAINST 6
AEM Holdings Ltd. April 23, 2025 Approve Grant of Awards and Issuance of Shares Under AEM Restricted Share Plan 2024 Compensation Board AGAINST 6
ANTA Sports Products Limited May 7, 2025 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 6
ANTA Sports Products Limited May 7, 2025 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 6
ATENOR SA April 25, 2025 Amend Article 6 of Bylaws to Reflect Changes in Capital Capital Structure Board AGAINST 6
ATENOR SA April 25, 2025 Approve Remuneration Policy Compensation Board AGAINST 6
ATENOR SA April 25, 2025 Approve Remuneration Report Compensation Board AGAINST 6
ATENOR SA April 25, 2025 Renew Authorization to Increase Share Capital within the Framework of Authorized Capital Capital Structure Board AGAINST 6
Addiko Bank AG April 18, 2025 Approve Management Board Remuneration Policy Compensation Board AGAINST 6
Addiko Bank AG April 18, 2025 Approve Supervisory Board Remuneration Policy Compensation Board AGAINST 6
Affin Bank Berhad April 16, 2025 Approve Allocation Under the Share Grant Scheme to Razly Abdullah Wan Ali Compensation Board AGAINST 6
Ainsworth Game Technology Ltd. May 28, 2025 Approve Remuneration Report Compensation Board AGAINST 6
Airbnb, Inc. June 4, 2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 6
Airbnb, Inc. June 4, 2025 To elect Amrita Ahuja, Joseph Gebbia and Jeffrey Jordan as Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Amrita Ahuja Director Elections Board WITHHOLD 6
Alibaba Health Information Technology Limited August 30, 2024 Adopt 2024 Share Award Scheme Compensation Board AGAINST 6
Alibaba Health Information Technology Limited August 30, 2024 Adopt Scheme Mandate Limit Compensation Board AGAINST 6
Alibaba Health Information Technology Limited August 30, 2024 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 6
Alibaba Health Information Technology Limited August 30, 2024 Approve Termination of 2014 Share Award Scheme Compensation Board AGAINST 6
Alibaba Health Information Technology Limited August 30, 2024 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 6
Alibaba Health Information Technology Limited August 30, 2024 Service Provider Sublimit Compensation Board AGAINST 6

← Previous Page 48 of 61 Next →

← Back to Dimensional 2024-2025 overview

Built November 1, 2026 from SEC Form N-PX filings.